| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.003 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.003 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.097 | 0.004 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.094 | 0.004 |